Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)

Clinical trial NCT00773734 · COMPLETED

Trial details

NCT number: NCT00773734
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Psoriasis Plaque-type Psoriasis

Start date: 2008-09-01
Primary completion: 2009-08-01
Enrollment: 352

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.